"Das Gesundheitszentrum Wetterau ist ein Zusammenschluss regionaler Krankenhäuser der Grund- und Regelversorgung. Mit hervorragenden medizinischen Leistungen unserer Ärzte, hoher Qualifikation und Motivation unseres Pflegepersonals, einem auf neuestem Stand befindlichen technischen Equipment und einer konsequenten Vernetzung mit den niedergelassenen Ärzten sowie mit den Universitätskliniken Gießen und Marburg innerhalb der Gesundheitsregion Mittelhessen sichern wir die medizinische Versorgung der Region auf hohem Niveau. Darüber hinaus bieten wir unseren Patientinnen und Patienten in den Zentren und interdisziplinären Schwerpunkten an unseren vier Standorten hoch spezialisierte Leistungen an."

During the past decade, Hochwaldkrankenhaus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hochwaldkrankenhaus" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hochwaldkrankenhaus" are "Breast Cancer" (3 trials) and "Triple-negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hochwaldkrankenhaus" in a lesser frequency.

Most popular intervention types in "Hochwaldkrankenhaus" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (4 trials), "5-Fluorouracil" (3 trials), "Docetaxel" (3 trials), "Doxorubicin" (3 trials) and "Epirubicin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hochwaldkrankenhaus" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hochwaldkrankenhaus". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hochwaldkrankenhaus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hochwaldkrankenhaus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".